Development of SARS-CoV-2 IgM and IgG antibodies in a relapsing multiple sclerosis patient on ofatumumab

We report the case of a MS patient on subcutaneous ofatumumab who became infected with SARS-CoV-2 and remained asymptomatic while developing antiviral IgM and IgG antibodies. The patient was B-cell depleted with normal serum immunoglobulin levels. Anti-SARS-CoV-2 IgG antibodies remained positive thr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mult Scler Relat Disord
Hlavní autoři: Flores-Gonzalez, Ramon E, Hernandez, Jeffrey, Tornes, Leticia, Rammohan, Kottil, Delgado, Silvia
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier B.V. 2021
Témata:
Correspondence
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7816891/
https://ncbi.nlm.nih.gov/pubmed/33508573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2021.102777
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky